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Consumption ofcontaminated Great 1Las fish bypregnant women is associatedwith decreased
birth weight and deficits in cognitive function in their infants and children. These fish contain
manyknown andsuspectedanthropogenicneurotoxicants, makdigitdifficultto determinewhich
contaminant(s) are responsible for the observed deficits. We have undertaken a series ofexperi-
ments to determine the relevant toxicants by comparing the neurotouic efifect of two of these
contaminants-polychorinated biphenyls (PCBs) and metylmercury (MeHg)-both ofwhich
are recognized neurotoxicants. Striatal punches obtained from adult rat brain were exposed to
PCBs only, MeHg only, or the two in combination, and tissue and media concentrations of
dopamine (DA) and its metabolites were determined by high performance liquid chromatogra-
phy. Exposure to PCBs onlyreducedtissue DAand elevatedmedia DAin adose-dependent fash-
ion. Exposure to MeHg only did not significantly affect either measure. However, when striatal
punches were simultaneously exposed to PCBs and MeHg, there were significantly greater
decreases in tissue DA concentrations and elevations in media DA than those caused by PCBs
only, inthe absenceofchangs in media lacte dehydrogenase concentrations. Elevations in both
tissue and media 3,4-dihydroxyphenylacetic acid concentrations were also observed. We suggest
that the significant interactions between these two toxicants may be due to a common site of
action (i.e., toxicant-induced increases in intracellular calcium and changes in second messenger
systems) that influences DA function. The synergism between these contamiants suggets that
future revisions offish-consumption guidelines should consider contaminat interactions. Key
wordk. dopamine, methyimercury, polychlorinated biphenyls, rat brain, striatal slice, synergism.
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An important but daunting task for toxicolo-
gists is elucidation of the interactive effects
and mechanisms ofaction ofindividual toxi-
cants that make up complex mixtures of
environmental contaminants. One of the
most relevant mixtures of toxicants in the
environment is found in contaminated fish,
particularly those from the Great Lakes.
Epidemiologic studies have demonstrated an
association between consumption ofcontami-
nated Great Lakes fish by mothers and
deficits in growth, development, and cogni-
tion in their infants and children (1-3).
Because polychlorinated biphenyls (PCBs), at
concentrations measured either in breast milk
or in fetal cord blood (4), have been associat-
ed with these deficits, it has been assumed
that PCBs are the contaminant responsible
for these deficits. However, Great Lakes fish,
indudingsalmon, contain many other known
and suspected developmental neurotoxicants,
including methylmercury (MeHg), chlorinat-
ed pesticides, and heavy metals (5,6). Thus, it
remains difficult, using only the tools ofepi-
demiology, to determine which contaminant
or contaminants are responsible for the
observed associations between maternal fish
consumption and developmental and cogni-
tivedeficits in their infants andchildren.
To begin to determine which fish-borne
contaminants alter central nervous system
function, and whether they interact func-
tionally or synergistically, we examined
changes in tissue and media concentrations
of dopamine (DA) following in vitro expo-
sure of striatal punches from adult rats to
PCBs or MeHg alone or in combination.
These compounds represent two of the
major neurotoxicants found in contaminated
Great Lakes salmon. We chose to initially
look for possible neurotoxic interactions
between these two contaminants because of
the extensive literature documenting the
neurotoxicity ofeach toxicant (7-9). For this
initial study we used striatal tissue punches,
rather than cells in culture, because the
explanted tissue conserves much ofthe neu-
ronal complexity and many of the neuro-
transmitter interactions of the intact brain.
We examined changes in DA function
because developmental exposure oflaborato-
ry rodents to lyophilized Great Lakes fish
containing the above contaminants results in
significant decreases in regional brain con-
centrations ofDA (10).
Methods
We initiallyexposed striatal punches to MeHg
at media concentrations ranging from 1 to 40
pM to determine the concentrations of the
toxicant thatwould alter DA function but not
induce tissue damage, defined as significant
elevations in media lactate dehydrogenase
(LDH) concentrations. Similarly, the PCB
doses chosen (10-200 ppm in exposure
media), which resulted in altered DAconcen-
trations in the absence of elevated media
LDH concentrations, were based on previous
striatal slice experiments conducted in our
laboratory (11).
After these initial experiments, we char-
acterized the neurochemical effects of com-
bined exposure ofstriatal slices to PCBs and
MeHg by exposing striatal punches from
naive adult male rats to a 1:1 Aroclor
1254/1260 mixture at concentrations rang-
ing from 10 to 200 ppm alone or in the
presence of different concentrations of
MeHg (4, 10, or 14 pM).
Preparation andincubation ofbrain tis-
sue. All experiments were performed with
the approval of the Wadsworth Center
Institutional Animal Care and Use
Committee. Naive male Wistar-derived rats,
approximately 90 days of age, were decapi-
tated and their brains removed and placed in
ice-cold saline. A forebrain block containing
the striatum was dissected by hand, mount-
ed on a vibratome, and four 350-pm thick
coronal slices were taken through the stria-
tum. The slices were transferred to a petri
dish containing ice-cold Hepes-buffered
Hank's saline (HBHS) and two 2-mm diam-
eter punches were obtained from each slice,
yielding eight striatal punches from each ani-
mal. These punches were distributed across
treatment conditions such that tissue from
each animal was tested at each exposure con-
dition. Individual punches were placed in
24-well culture plates containing 500 pL
HBHS supplemented with 1% horse serum
and 0.2% dimethylsulfoxide (DMSO) (vehi-
cle control) or 0.2% DMSO containing the
test compounds of interest. The tissue was
incubated for 4 hr in a 37°C shaking water
bath under an atmosphere of 95% 02/5%
CO2. The 4-hr incubation was chosen based
on our previous experiments demonstrating
Address correspondence to R.F. Seegal, New York
State Department of Health, Wadsworth Center,
Box 509, Albany NY 12201-0509. Telephone:
(518) 473-4378. Fax: (518) 486-1505. E-mail: see-
gal@wadsworth.org
Research support for this work was provided in
part by NIEHS Superfund Basic Research Program
grant P42 ES04913 and NIEHS grant ROI
ES07921 to R.F. Seegal.
Received 2 March 1999; accepted 24June 1999.
Environmental Health Perspectives * Volume 107, Number 1 1, November 1999 879Articles * Bemis and Seegal
significant effects of PCB exposure on DA
concentrations in striatal slices, without the
extreme reductions in dopamine content
observed at 6 hr incubation (12). Thus, we
were able to examine for potential interac-
tions between PCBs and MeHg.
Preparation ofcontaminant solutions
and selection ofdoses. The contaminants
included PCBs (a 1:1 mixture ofAroclors
1254 and 1260) at concentrations of 10, 20,
40, 100, or 200 ppm and MeHg at concen-
trations of 1, 4, 10, 14, 20, or 40 pM. The
PCB mixture was chosen because we previ-
ously demonstrated homology between the
PCB congeners in this mixture and those
found in contaminated Great Lakes fish (5).
For the PCB/MeHg interaction experiments
we chose concentrations of MeHg-4, 10,
and 14 pM-that yielded no effect to mini-
mal effects on our end points without induc-
ing elevations in media LDH concentra-
tions. Stock solutions of each toxicant were
dissolved in DMSO and diluted in the expo-
sure medium, resulting in a final DMSO
concentration of0.2%.
HPLC analysis ofdopamine and its
metabolites. After the 4-hr incubation, a
200-jiL aliquot ofmedia from each well was
diluted 1:1 with 0.4 N perchloric acid, and
striatal punches were homogenized in 300
pL 0.2 N perchloric acid. Supernatants from
both the tissue homogenates and the per-
chloric acid-diluted media were analyzed for
DA and its metabolites [3,4-dihydrox-
yphenylacetic acid (DOPAC) and homo-
vanillic acid (HVA) (media samples only)]
by HPLC with electrochemical detection as
described in Seegal et al. (13).
Measurement ofmedia LDH. In parallel
experiments, striatal punches, harvested as
described above, were incubated in media
containing 0.2% DMSO (control), 4, 10, or
14 pM MeHg only, 100 or 200 ppm PCBs
only, or various combinations of PCBs and
MeHg. After incubation, the media were
removed and analyzed for LDH content
using the Sigma Diagnostics LDH Assay
(Sigma, St. Louis, MO) based on the tech-
nique ofAmador et al. (14).
'Statistical analyses. Data are presented
from 14 individual experiments that used a
range of PCB and MeHg concentrations
tested either alone or in combination. The
design of each experiment, using 48 tissue
punches assigned to treatments in a counter-
balanced manner, allowed for either 8 or 12
conditions to be tested with either 6 or 4
punches at each condition, respectively. It
was not possible to test all treatment condi-
tions in a single experiment. Because of the
variable number of observations and the
variance at each test condition, we analyzed
the data using the Brown-Forsythe analysis
of variance (ANOVA) test, in which the
variances in each experimental treatment are
not assumed to be equal (15). This conserva-
tive test controls for unequal cell size by
weighting the variance according to the
number ofobservations.
Dose-response effects of either PCBs or
MeHg alone were analyzed using one-way
ANOVA with Bonferroni-corrected post hoc
t-tests to compare each dose to control.
Interactions between varying concentrations
ofPCBs, in the presence or absence ofa con-
stant concentration of MeHg, were analyzed
using two-wayANOVAwith Bonferroni-cor-
rected post hoc t-tests to compare the effects
of each combined treatment with the effect
induced by the corresponding concentration
ofPCBs alone. Finally, because ofsmall varia-
tions in the control punch DA concentrations
between individual experiments, we expressed
the data from each experiment as a percentage
of its average control value, thus reducing
interexperiment variance. The range of
absolute values for control tissue and media
samples are presented in "Results."
Results
Experiments that examined various exposure
times to PCBs, MeHg, and combinations of
both revealed no significant effects on the
chosen end points before 4 hr (data not
shown). Thus, all data represent 4-hr expo-
sure to the previously described treatment
conditions. The data presented, expressed as
percent of DMSO control values, should be
interpreted with regard to the absolute con-
centrations oftissue and media DA: 372.9 ±
8.9 and 6.2 ± 1.4 ng/mg tissue protein,
respectively. The absolute concentrations of
DOPAC in tissue and media exposed to con-
trol treatments are 8.9 ± 0.35 and 140.7 ±
7.4 ng/mg tissue protein, respectively. Thus,
the apparently large elevations in media DA
expressed as a percent ofcontrol values actu-
ally represent a relatively small change in
absolute DA concentrations as compared to
the large changes in absolute tissue DA con-
tent induced by these toxicants.
Effects ofMeHg on dopaminefunction.
Exposure of striatal punches to MeHg at
concentrations ranging from 1 to 40 pM
resulted in a significant dose-dependent
decrease in tissue DA concentrations [F =
85.38; degrees offreedom (df) = 6, 68; p <
0.001]. Results at concentrations of MeHg
at 20 and 40 pM were significantly different
from control values (Table 1).
In contrast, exposure to MeHg resulted
in a significant dose-dependent increase in
media DA concentrations (F= 55.98; df=
6, 16; p < 0.001). Results at 14, 20, and 40
pM MeHg were significantly different from
control (Table 1).
Tissue concentrations of DOPAC were
significantly reduced after exposure to 4, 10,
20, and 40 pM MeHg (p < 0.05 to p <
0.001), although media DOPAC concentra-
tions were elevated only at the 20 pM dose
of MeHg (Table 1). The concentrations of
HVA in media from punches exposed to all
concentrations ofMeHg (except 1 pM) were
significantly reduced as compared to control
values (p < 0.05 to p < 0.001) (data not
shown). On the basis of these results, we
chose three concentrations ofMeHg (4, 10,
Table1. DA and DOPAClevelsa in tissue and media from striatal punches exposed to MeHg.
MeHg (pM)b Tissue DA Media DA Tissue DOPAC Media DOPAC
0 100.0± 1.8c 100.0± 6.3c 100.0± 3.4c 100.0 ±3.0c
1 102.8± 3.1 73.3± 10.1 95.4± 7.7 100.1 ± 3.7
4 102.2 ± 2.6 116.4± 11.0 84.1 ±4.0** 94.6 ± 2.8
10 95.0 ± 2.6 129.7± 11.2 83.1 ±4.2** 96.5 ± 3.2
14 83.6 ± 6.6 268.3 ± 48.2* 105.0 ± 10.4 103.9 ± 6.1
20 19.4 ± 5.8" 1,767.3 ± 325.6# 66.2 ± 6.7# 181.9 ± 8.6##
40 0.687 ± 0.132#" 3,299.6 ± 235.5## 13.5 ±3.3## 81.1 ±7.2
Abbreviations: DA, dopamine; DOPAC,3,4-dihydroxyphenylacetic acid; MeHg, methylmercury.
'Mean + standard error, expressed as a percent of the dimethyl sulfoxide control. bbn = 6-84 punches (wells) per dose.
cAbsolute concentrations of tissue and media DA were 372.9 ± 8.9 and 6.2 ± 1.4 nglmgtissue protein, respectively, and
tissue and media DOPAC were 8.9 ± 0.35 and 140.7 ± 7.4 ng/mg tissue protein, respectively. *p < 0.1. **p <0.05. #p <0.01. ap' 0.001.
Table2. DA and DOPAClevels"intissue and media from striatal punches exposed toAroclor 1254/1260.
Aroclor
1254/1260 (ppm)b Tissue DA Media DA Tissue DOPAC Media DOPAC
0 100.0 ± 1.7c 100.0 ± 6.0c 100.0 ± 3.4c 100.0 ± 3.0c
10 89.5 ± 2.4** 206.3 ± 27.2* 120.8 ± 9.0* 117.8 ± 5.1
20 86.5±2.8' 233.4±26.5** 108.5±3.6* 119.6±5.9
40 78.6 ±1.7# 340.6 ±29.2# 114.8 ±5.4# 123.1 ±4.0
100 68.4 ± 2.1# 438.2 ±32.0' 135.5 ± 5.7' 133.7 ± 4.2#
200 58.9 ± 1.9# 478.2 ±34.0# 181.7 ± 7.7' 153.2 ± 5.3'
Abbreviations: DA, dopamine; DOPAC,3,4-dihydroxyphenylacetic acid.
aMean ± standard error, expressed as a percent ofthedimethyl.sulfoxide control. bn = 23-83 punches(wells) per dose.
cAbsolute concentrations tissue and media DA were 372.9 ± 8.9 and 6.2 ± 1.4ng/mg tissue protein, respectively, and tis-
sue and media DOPAC were 8.9 ± 0.35 and 140.7 ± 7.4ng/mg tissue protein, respectively. *p<0.05. **p<0.01.'p <0.001.
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and 14 pM) to examine for potential inter-
actions with PCBs. These three doses of
MeHg spanned the range ofdoses from no
effect at4 pM MeHg to small nonsignificant
effects on DA function, in the absence of
gross alterations in DA concentrations or
changes in media LDH, at 14 pM.
Effects ofPCBs on dopaminefunction.
Exposure to the Aroclor 1254/1260 mixture
at media concentrations ranging from 10 to
200 ppm resulted in a significant dose-
dependent decrease in tissue DA concentra-
tions (F = 63.64; df= 5, 212; p < 0.001),
with all doses significantly different from
control at the p < 0.01 or p < 0.001 level
(Table 2, Figure 1).
Exposure to PCBs also resulted in a sig-
nificant dose-dependent increase in media
DA concentrations (F= 38.31; df= 5, 178;
p < 0.001) with all doses significantly differ-
ent from control values at the p < 0.05 to p
< 0.001 level (Table 2, Figure 2). However,
the net effect ofPCB exposure was a reduc-
tion in total DA concentrations (i.e., punch
DA + media DA).
Tissue DOPAC concentrations were sig-
nificantly elevated after exposure to 100 and
200 ppm PCBs (p < 0.001) (Table 1). In
addition, a significant dose-dependent
increase in media DOPAC concentrations
(F = 19.81; df= 5, 202; p < 0.001) was
observed after exposure to PCBs, with all
doses significantly different from control at
thep < 0.05 top < 0.001 level. Media HVA
concentrations were unchanged after expo-
sure to any doses ofPCBs (data not shown).
These results are comparable to those report-
ed by Chishti et al. (11) using similar con-
centrations of an identical 1:1 Aroclor
1254/1260 mixture.
Effects ofcombinedPCBs andMeHg on
dopaminejWnction. The effects ofcoexposure
ofstriatal tissue to MeHgand PCBs on tissue
and media concentrations of DA and
DOPAC are shown in Figures 1-4. In each
panel the indicatedp-values rdpresent the sig-
nificance ofthe interaction determined using
two-way ANOVA with a significant P-value
indicating that the slopes of the lines differ
and a significant interaction exists when stri-
atal tissue wasexposed to both contaminants.
Combined exposure to 4 pM MeHg and
200 ppm PCBs (Figure IA) resulted in a sig-
nificant MeHg x PCB statistical interaction
(F = 3.07; df= 5, 78; p < 0.05). This treat-
ment resulted in nonsignificant reductions
in media DA concentrations at PCB concen-
trations below 40 ppm and an increase in
media DA concentrations above 40 ppm
(Figure 2A), resulting in astatisticallysignifi-
cant MeHg x PCB interaction (F= 2.56; df
= 5, 51;p< 0.05).
Combined exposure to 10 pM MeHgand
20, 40, 100, or 200 ppm PCBs (Figure iB)
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Figure 1. Effect of (A) 4 pM methylmercury, (8)10
pM MeHg, or (C) 14 pM MeHg alone or in combi-
nation with varying concentrations of a 1:1 mix-
ture of 54/60 (10-200 ppm) (PCB) on striatal punch
concentrations of dopamine after a 4-hr incuba-
tion. Abbreviations: 54/60, Aroclor 1254 + 1260;
OMSO, dimethyl sulfoxide; MeHg, methylmercury;
PCB, polychlorinated biphenyl. For each concen-
tration, data from 2-14 experiments were com-
bined and are expressed as a percent of the
DMSO (vehicle) control. The absolute dopamine
concentrations in the control punches were 372.9
± 8.9 ng/mg tissue protein. The MeHg x PCB p-
value indicates the significance of the MeHg by
PCB interaction.
*p . 0.1, **P . 0.05, 'p . 0.01, or"*p . 0.001 indicates the
significance of post hoc t-tests comparing the combined
MeHg + PCB treatment with respect to the correspond-
ing dose of PCBs alone.
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Figure 2. Effect of (A) 4 pM methylmercury, (B) 10
pM MeHg, or (C) 14 pM MeHg alone or in combi-
nation with varying concentrations of a 1:1 mix-
ture of 54/60 (10-200 ppm) (PCB) on media con-
centrations of dopamine after a 4-hr incubation of
striatal punches as described in Figure 1.
Abbreviations: 54/60, Aroclor 1254 + 1260; DMSO,
dimethyl sulfoxide; MeHg, methylmercury; PCB,
polychlorinated biphenyl. For each concentration,
data from 2-14 experiments were combined and
are expressed as a percent ofthe DMSO (vehicle)
control. The absolute dopamine concentrations in
media from control punches were 6.2 ± 1.4 ng/mg
tissue protein. The MeHg x PCB p-value indicates
the significance ofthe MeHg by PCB interaction.
*ps0.1, **p.0.05, or#p. 0.01 indicates the significance
of post hoc t-tests comparing the combined MeHg + PCB
treatment with respect to the corresponding dose of
PCBs alone.
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Figure 3. Effect of (A) 4 pM methylmercury, (B) 10
pM MeHg, or (C) 14 pM MeHg alone or in combi-
nation with varying concentrations of a 1:1 mix-
ture of 54/60 (10-200 ppm) (PCB) on striatal
punch concentrations of DOPAC after a 4-hr
incubation. Abbreviations: 54/60, Aroclor 1254 +
1260; DOPAC, 3,4-dihydroxyphenylacetic acid;
DMSO, dimethyl sulfoxide; MeHg, methylmer-
cury; PCB, polychlorinated biphenyl. For each
concentration, data from 2-14 experiments were
combined and are expressed as a percent of the
DMSO (vehicle) control. The absolute DOPAC
concentrations in the control punches were 8.9 ±
0.35 ng/mg tissue protein. The MeHg x PCB p-
value indicates the significance of the MeHg by
PCB interaction.
*p < 0.1 indicates the significance of post hoc t-tests
comparing the combined MeHg + PCB treatment with
respectto the corresponding dose of PCBs alone.
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Figure 4. Effect of (A) 4 pM MeHg, (B) 10 pM
MeHg, or (C) 14 pM MeHg alone or in combination
with varying concentrations of a 1:1 mixture of
54/60 (10-200 ppm) (PCB) on media concentrations
of DOPAC following a 4-hr incubation of striatal
punches as described in Figure 1. Abbreviations
54/60, Aroclor 1254 + 1260; DOPAC, 3,4-dihydrox-
yphenylacetic acid, DMSO, dimethyl sulfoxide;
MeHg, methylmercury; PCB, polychlorinated
biphenyl. For each concentration, data from 2 14
experiments were combined and are expressed as
a percent of the DMSO (vehicle) control. The
absolute DOPAC concentrations in media from
control punches were 140.7 ± 7.4 ng/mg tissue
protein. The MeHg x PCB p-value indicates the
significance ofthe MeHg by PCB interaction.
*p .005 indicates the significance of post hoc t-tests
comparing the combined MeHg + PCB treatment with
respectto the corresponding dose of PCBs alone.
also significantly decreased tissue DA con-
centrations as compared to exposure to
PCBs alone (p < 0.001), resulting in a signif-
icant MeHg x PCB statistical interaction (F
=5.09; df= 5, 57;p<0.001).
Combined exposure to 14 pM MeHg
andvarying concentrations ofthe 1:1 Aroclor
1254/1260 mixture (Figure IC) also signifi-
cantly decreased tissue DA concentrations,
with combined exposure to all doses ofPCB
(except 10 ppm PCB) significantly different
from exposure to PCBs only at either thep <
0.05 or p < 0.001 level, resulting in a
significant MeHg x PCB statistical interac-
tion (F = 3.45; df= 5, 53; p < 0.01). This
treatment also increased media DA concen-
trations (Figure 2C) with exposure to 14 pM
MeHg only; 14 p1M MeHg combined with
40, 100, and 200 ppm PCB was significantly
different from exposure to PCBs only at the
p < 0.1 top < 0.01 level, which resulted in a
MeHg x PCB statistical interaction (F =
9.39; df= 5, 18; p < 0.001). As with PCB-
only exposure, the net effect on total DA
(punch + media) was asignificant reduction.
DOPAC concentrations were elevated in
tissue exposed to 14 pM + 40 ppm PCBs
only (p < 0.1) (Figure 3C) and media from
tissue exposed to 14 pM MeHg combined
with 200 ppm PCB (p < 0.05) (Figure 4C).
Thus, the overall trend in elevations oftissue
and media DOPAC concentrations in
punches treated with 14 pM MeHg and
PCB led to a significant statistical MeHg x
PCB interaction in both tissue (F= 2.91; df
= 5, 34; p < 0.05) and media (F= 3.24; df=
5, 27; p < 0.05) samples. This was the only
dose of MeHg (14 pIM) at which a statisti-
cally significant PCB x MeHg interaction
was observed on tissue or media DOPAC
concentrations.
Table 3. Media LDH levelsa from striatal tissue
exposed to DMSO control, 54/60, MeHg, or combi-
nations of both.
Exposure conditionb Media LDH
DMSO control
0.2% 60.7 ± 2.2
54/60
100 ppm 58.8 ± 2.4
200 ppm 68.4 ± 6.5
MeHg
4pM 64.0±1.4
10pM 65.4± 5.0
14pM 66.9±3.6
20 pM 72.1 ± 4.9**
54/60 + MeHg
4pM MEHG + 100 ppm 54/60 59.8 ± 4.3
10 pM MEHG + 100 ppm 54/60 65.6 ± 7.0
14 pM MEHG + 100 ppm 54/60 70.9± 2.6**
14 pM MEHG + 200 ppm 54/60 69.9± 6.8*
Abbreviations: 54/60, Aroclor 1254/1260; DMSO, dimethyl
sulfoxide; LDH, lactate dehydrogenase; MeHg,
methylmercury.
'Mean ± standard error, expressed in international
units/liter. bn = 3-7 punches (wells) per treatment. *p <
0.1. **p<0.05.
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The addition of 10 or 14 pM MeHg to
any of the PCB doses resulted in a simple
additive reduction in media HVA concentra-
tions as compared to PCB-only exposed tissue
(data not shown). There were no interactive
effects observed for HVA after exposure to
anyofthe combinations ofPCBs and MeHg.
Effects oftoxicant exposure on media
concentrations ofLDH. To determine ifthe
toxicants alone or in combination induced
nonspecific cytotoxic effects, we measured
the concentration of LDH released into
media, expressed in international units. We
chose to use this measure of tissue viability
because the measurement of LDH release
into media is a commonly used measure of
cellular and tissue toxicity (16,17), particu-
larlywhen applied to organotypic cultures.
Media LDH levels were unaffected after
exposure to MeHg at concentrations < 14
pM (Table 3). Media LDH concentrations
were not significantly altered after exposure
to PCBs at any ofthe concentrations used in
this study [results similar to those reported
in Chishti et al. (11)]. However, after com-
bined exposure to 14 pM MeHg and 100
ppm PCBs, a significant (at p < 0.05) eleva-
tion in media LDH was observed, although
there was no statistical difference in the com-
bined 14 pM MeHg and 200 ppm PCB
exposure condition.
Discussion
This study is part ofa larger project to deter-
mine the neurologic (i.e., behavioral and neu-
rochemical) effects ofdevelopmental exposure
oflaboratory rodents to the toxicants present
in Great Lakes salmon. Although the concen-
trations of PCBs and MeHg used in these
experiments are higher then those seen in
Great Lakes fish (PCB content ranged from
0.84 to 1.9 ppm, whereas mercury concentra-
tions were 0.34 ppm) (5,6), the concentra-
tions ofthese contaminants are similar to, or
lower than, those used in other in vivoand in
vitro studies (18-21). Furthermore, some
human populations consume contaminated
pilot whale meat that contains PCB concen-
trations as high as 30 ppm and mercury levels
in the range of3.3 ppm (22), well within our
range ofdoses. As presented, these results pro-
vide the first evidence of a significant func-
tional interaction between two of the major
neurotoxicants present in contaminated Great
Lakes salmon and other freshwater and
marine species-PCBs and MeHg. To under-
stand the potential mechanisms for the inter-
actions between these contaminants, it is
appropriate to first discuss the mechanisms by
which the individual contaminants alter
DAfunction.
PCB effects on dopaminefunction. The
data we gathered in intact animals, PC12
cells, and striatal slices exposed to PCBs
suggest two distinct but interdependent
mechanisms that may be responsible for the
decreases in DA concentrations observed
after exposure to PCBs.
First, PCBs reduce tissue DA concentra-
tions in the above test systems (10,11,23),
most likely due to the inhibition oftyrosine
hydroxylase (TH), the rate-limiting enzyme in
DA synthesis. Inhibition ofTH by PCBs has
been demonstrated in striatal slices exposed to
NSD-1015, which inhibits aromatic amino
acid decarboxylase (AADC). AADC is the
enzyme that converts 3,4-dihydroxyphenylala-
nine (L-DOPA), an intermediate product
formed by the TH catalyzed conversion of
tyrosine, to DA (24). Thus, PCBs reduce L-
DOPA content in striatal slices after exposure
toNSD-1015 + PCBs, demonstrating an inhi-
bition of TH activity (12). In addition,
Choksi et al. (25) reported reductions in TH
activity in rat brain striatal minces exposed to
specific ortho-substituted PCB congeners.
Second, in both striatal slices (11) and
punches (data presented here) we noted sig-
nificant elevations in media concentrations of
DA, which we believe is a reasonable surro-
gate for changes that occur in the extracellu-
lar space of the tissue punch or the brain.
These elevations may be due to PCB-
enhanced neurotransmitter release and/or
inhibition of DA uptake at either the
dopamine transporter (DAT) or the vesicular
monoamine transporter (VMAT). Thus,
Messeri et al. (26) reported elevations in
spontaneous DA release from bovine chro-
maffin cells exposed to PCBs-results similar
to those obtained in our experiments.
Furthermore, Mariussen et al. (27) showed
that ortho-substituted PCBs inhibit DA
uptake byVMAT invesicles isolated from rat
striatal synaptosomes, resulting in elevated
media levels of DA. The reported elevations
ofboth tissue and media DOPAC concentra-
tions further support the proposed increases
in intracellular DA levels because DOPAC is
formed from free intracellular DA via the
action of intracellular monoamine oxidase
(MAO) (28). Thus, increased tissue and
extracellular DOPAC concentrations may
reflect increased free intracellular DAconcen-
trations elicited by exposure to PCBs. In
addition, elevations in free intracellular DA
concentrations result in end-product inhibi-
tion ofTH activity (29,30) and elevations in
extracellular DA by a carrier-mediated
process that moves DA out of the terminal
via DAT (31). Thus, elevations in extracellu-
lar DA or exposure to DA agonists result in
activation of presynaptic DA autoreceptors
and inhibition ofDA synthesis at the level of
TH (32,33).
HVA is formed from extracellular DAby
the catabolic activity ofcatechol-0-methyl-
transferase (COMT) and MAO (28). The
reported elevations in media DA elicited by
exposure to PCBs or MeHg would be
expected to result in increased media HVA
concentrations. However, the lack of effect
on media HVA reported here has previously
been observed in our in vitro preparation
after exposure to PCBs (11) and most likely
represents the effects ofrelatively short incu-
bation times and the relatively small eleva-
tions in absolute media DA concentrations
as compared to the large overall reduction in
tissue DAcontent.
In summary, these data provide evidence
that PCBs inhibit the syntheticactivityofTH
in several model systems. We suggest that the
elevations in media DA and, by inference,
extracellular DA concentrations represent an
initial event induced by PCB exposure
which, by the mechanisms described above,
contributes to the PCB-induced decrease in
DAsynthesis.
MeHg efects on dopamine. Both in vivo
and in vitro exposure to MeHg alters DA
function. Using a mouse striatal slice prepara-
tion similar to the one used here, MeHg
exposure, at concentrations considerably
higher than we used (i.e., 50 pM), resulted in
significantly elevated media DA concentra-
tions (20). Similarly, when adult rats were
exposed intraperitoneally to MeHg at concen-
trations ranging from 0.1 to 2 mg/day (for a
total dose of4 or 6 mg), DA concentrations
in striatal dialysates obtained by in vivo
microdialysis weresignificantlyelevated (21).
Both groups of investigators concluded
that the MeHg-induced increases in extracel-
lular DA concentrations may be due to
enhanced DA release. These results are simi-
lar to those obtained by Komulainen (34),
who exposed striatal synaptosomes to MeHg
and reported dose-dependent inhibition of
uptake of DA and enhanced release of DA
from synaptosomes.
Combinedeffects ofPCBs andMeHg on
dopaminefunction. The major effects of
combined exposure of striatal punches to
PCBs and MeHg are a reduction in punch
DA concentrations and an increase in media
DA concentrations beyond that seen after
exposure to PCBs or MeHg separately.
There are several possible explanations for
this synergism, which suggests a similar site
ofaction.
Both PCBs and MeHg elevate intracellu-
lar Ca2, in in vitro neuronal cell prepara-
tions, and elevations in intracellular Ca2+
alter DA function. Kodavanti et al. (19)
exposed cerebellar granule cells to ortho-sub-
stituted PCB congeners and demonstrated a
significant increase in intracellular calcium
concentrations. Similarly, Pessah (35)
demonstrated elevations in intracellular cal-
cium in PC12 cells after exposure to ortho-
substituted PCB congeners. These elevations
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are due to PCB-induced activation of intra-
cellular ryanodine channels that act as release
sites for calcium sequestration stores in
endoplasmic reticulum and mitochondria.
MeHg exposure also results in elevations in
intracellular calcium concentrations in both
continuous cell lines and primary cells.
Using the calcium-sensitive dye fura 2,
Marty and Atchison (36) demonstrated a
two-component elevation in intracellular cal-
cium in cerebellar granule cells exposed to
MeHg. They concluded that the smaller,
more rapid onset increase in intracellular cal-
cium involved MeHg-induced liberation of
calcium from inositol 1,4,5-triphosphate
(IP3)-sensitive intracellular stores.
The second and larger elevation in intra-
cellular calcium involved the influx ofextra-
cellular calcium due to MeHg acting on
multiple sites ofentryofextracellular calcium
into granule cells. Furthermore, Minnema et
al. (37) showed that exposure of mitochon-
dria isolated from whole rat brain to MeHg
results in significant efflux oflabeled calcium
from these calcium storage organelles. These
effects again complement the action ofPCBs
on the disruption of intracellular calcium
homeostasis via sequestration of calcium in
mitochondria. Finally, in cultured cerebellar
granule cells exposed to MeHg, Sarafian (38)
observed increased intracellular calcium as
well as 1P3 levels. He demonstrated that
MeHg did not directly activate protein
kinase C (PKC), but most likely functions
through one or both of the reported eleva-
tions in the second messengers, calcium and
1P3. Verity (351) published a more complete
reviewofMeHgeffects on calcium.
The similar actions ofthese two environ-
mental toxicants on regulation ofintracellular
calcium concentrations suggest a potential
mechanism that might account for their sig-
nificant interactive effects on the release of
DA into media and on DA synthesis.
Hanneman et al. (40) reported thatelevations
in intracellular calcium in rat hippocampal
slices, induced by exposure to 2,3,7,8-tetra-
chlorodibenzo--dioxin, increased the activity
of PKC. In turn, activation of PKC in both
mouse and rat striatal synaptosomes led to
phosphorylation ofDAT (41,4), resulting in
increased extracellular DA concentrations.
Furthermore, an increase in intracellular cal-
cium can also initiate the release ofDA from
synaptic vesicles docked at the plasma mem-
brane (43). Thus, toxicant-induced eleva-
tions in intracellular calcium may lead to
both inhibition of DA uptake, mediated by
DAT, and enhanced release of intracellular
DA-events thatultimately result in decreased
DAsynthesis (32,33).
It is also conceivable that the observed
interactive effects on punch DA concentra-
tions are toxicokinetic in nature (i.e., either
MeHg increases the intracellular concentra-
tions ofPCBs or PCBs increase intracellular
concentrations of MeHg). However, we
believe that elevated toxicant levels were not
responsible for the observed interactions,
particularly in punches exposed to either 4
or 10 pM MeHg plus PCBs, for the follow-
ing reasons. First, in preliminary studies
(data not shown) there were no differences
in PCB content between PCB- and PCB +
MeHg-exposed punches. Second, there were
no detectable differences in media LDH
concentrations, except for the 14 ,uM +
PCB-exposed punches. These data not only
suggest that the preparations wereviable, but
also suggest that MeHg exposure, at least at
the 4 and 10 pM MeHg concentrations used
in these experiments, did not significantly
alter membrane permeability and, by infer-
ence, increase intracellular concentrations of
the toxicants.
In summary, we have shown that expo-
sure of rat striatal punches to PCBs and
MeHg decreases punch DA content and ele-
vates media DA levels to a greater extent than
exposure to the single toxicants alone in the
absence ofsignificant changes in media LDH
concentrations, which provides a recognized
measure of both the integrity of the plasma
membrane and the viability of the striatal
punch. The magnitude of the decrease in
punch DA content after combined exposure
to MeHg and PCBs (a 20-50% decrease
depending on the level of the contaminants
studied) is not as great as thatseen in rat brain
after developmental exposure to the complex
mixture of contaminants found in Great
Lakes salmon (10). Although there are
methodologic differences between these stud-
ies (e.g., in vivovs. in vitro), we suggest that a
major difference is related to the greater num-
ber of putative neurotoxicants present in the
contaminated fish as compared to the two
neurotoxicants studied here. Examination of
binary pairs of contaminants (e.g., MeHg +
PCBs) is but a preliminary step in the investi-
gation ofthe neurotoxic potential ofcomplex
contaminant mixtures. Thus, we have begun
to examine functional interactions between
PCBs and other fish-borne contaminants,
including the chlorinated pesticide chlordane,
and we demonstrated similar changes in stri-
atal punch DA function. Examination ofthe
neurotoxic actions oftertiaryandhigherorder
combinations of toxicants provides a logical
next step toward understanding the actions of
complex mixtures of environmentally rele-
vant toxicants on nervous system function.
Thus, our results warrant examination ofthe
impact of other environmental mixtures on
human health, suggest that future fish-con-
sumption advisories consider the likelihood
that environmental contaminants may act
synergistically, and provide a strong rationale
for examining for possible interaction effects
ofthis and other contaminant mixtures in the
intact developing animal.
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